Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

819
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
819

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrochemical Probing of Dopamine Dynamics During Poly(I:C)-Induced Neuroinflammation.

Small (Weinheim an der Bergstrasse, Germany)·2024
Same author

Fibrillarin homologs regulate translation in divergent cell lineages during planarian homeostasis and regeneration.

The EMBO journal·2024
Same author

Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomas.

bioRxiv : the preprint server for biology·2024
Same author

Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer.

Journal of gastrointestinal oncology·2024
Same author

HSTrans: Homogeneous substructures transformer for predicting frequencies of drug-side effects.

Neural networks : the official journal of the International Neural Network Society·2024
Same author

Physical Origin of the Ferroelectric-Type Hysteresis in MIM Structures with Amorphous Dielectric Film.

ACS applied materials & interfaces·2024
Same journal

STED: flexible cross-modal topic modeling infers cell-type-specific regulatory landscapes from bulk epigenomics.

Briefings in bioinformatics·2026
Same journal

A knowledge-guided deep learning framework for quantitative nucleic acid testing.

Briefings in bioinformatics·2026
Same journal

Optimal transport for label transfer in single-cell multi-omics integration.

Briefings in bioinformatics·2026
Same journal

Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity.

Briefings in bioinformatics·2026
Same journal

Evaluating completeness, coherence, and consistency of genome-scale function annotations.

Briefings in bioinformatics·2026
Same journal

Transformers for single-cell RNA sequencing: a survey.

Briefings in bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Aug 2, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Decoding Connectivity Map-based drug repurposing for oncotherapy.

Yuanchun Zhao1, Xingqi Chen1, Jiajia Chen1

  • 1School of Chemistry and Life Sciences, Suzhou University of Science and Technology, Suzhou, 215011, China.

Briefings in Bioinformatics
|April 17, 2023
PubMed
Summary
This summary is machine-generated.

Drug repurposing using the Connectivity Map (CMap) database offers a cost-effective way to find new anti-cancer drugs. This computational approach accelerates the discovery of novel cancer therapies by analyzing gene expression data.

Keywords:
Connectivity Mapcancerdrug discoverydrug repurposinggene expression signatureoncotherapy

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Related Experiment Videos

Last Updated: Aug 2, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Area of Science:

  • Oncology
  • Pharmacology
  • Bioinformatics

Background:

  • The increasing global cancer burden necessitates novel therapeutic strategies.
  • Traditional drug discovery is time-consuming, expensive, and high-risk.
  • Transcriptome profiling technologies have advanced significantly.

Approach:

  • This review explores drug repurposing for anti-cancer drug discovery.
  • It focuses on the Connectivity Map (CMap) database and its applications.
  • Novel CMap-based computational approaches and algorithms are summarized.

Key Points:

  • The Connectivity Map (CMap) database facilitates systematic discovery of gene-disease-compound associations.
  • CMap enables elucidation of drug mechanisms of action for anti-cancer pharmacotherapy.
  • Computational drug repurposing using CMap overcomes traditional drug discovery bottlenecks.

Conclusions:

  • CMap-based drug repurposing shows significant potential for discovering effective anti-cancer agents.
  • This approach can accelerate the development of efficient cancer therapies.
  • It promises to improve healthcare outcomes for cancer patients.